Alessandro Giacometti

Alessandro Giacometti joined VIVUS in October 2022 as Vice President & General Manager Europe. Prior to that, during his 31 years in the pharmaceutical industry, Mr. Giacometti served at Roche, Pfizer, sigma-tau and Takeda. He started his career in 1991 at Roche Italy as a medical rep in his hometown, Rome. Between 1995 and 1998 he served as the CNS brand manager at Roche Italy, based in Milano’s headquarters. Mid-1998 he joined Pfizer Italy where he held positions in marketing and business development (commercial assessment of pipeline phase II/III). In 2000 he joined sigma-tau, an Italian company, as Marketing Director for the cardiovascular and metabolic portfolio, returning to Pfizer in 2011 and being appointed Business Development Team Leader (pipeline and licensing in). In 2005 he started his international career with Pfizer relocating to the UK and taking the role of Team Leader/Marketing Director, Europe & Canada, for the cardiovascular and pain/inflammation categories. In 2011 he was promoted to Senior Marketing Director, Emerging Markets leading the team managing the Pfizer portfolio. In late 2012 Mr. Giacometti joined Takeda International, relocating to Switzerland, where he held positions as Head of the Cardiovascular Portfolio, Head of Commercial Assessment of External Opportunities and Global Product Lead until 2016. From July 2016 until August 2022, he served as Takeda’s Global Commercial Lead, leading the global launch of a breakthrough treatment based on stem cells.

Mr. Giacometti earned his University Degree in Geology from the University of Rome, “La Sapienza”. Mr. Giacometti, an Italian citizen, will be based in Switzerland where he lives with his family.